Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities

Chemistry and Biology

Volumn 14, Issue 4, 2007, Pages 431-441

  Mollica, Luca ^a   De Marchis, Francesco ^b   Spitaleri, Andrea ^a   Dallacosta, Corrado ^a   Pennacchini, Danilo ^a   Zamai, Moreno ^b   Agresti, Alessandra ^b   Trisciuoglio, Lisa ^b   Musco, Giovanna ^a   Bianchi, Marco E ^b,c  

^a DULBECCO TELETHON INSTITUTE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

CHEMBIOL; MOLIMMUNO

Indexed keywords

CYTOKINE; DNA; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; MITOGENIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ARTICLE; BINDING SITE; CELL STRAIN 3T3; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; FLUORESCENCE; HUMAN; METABOLISM; MOUSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING;

3T3 CELLS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BINDING SITES; CYTOKINES; DNA; FLUORESCENCE; GLYCYRRHIZIC ACID; HMGB1 PROTEIN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MITOGENS; MODELS, MOLECULAR; PROTEIN BINDING;

EID: 34247181253     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2007.03.007     Document Type: Article

References (47)

1. Bianchi M.E., Beltrame M., and Paonessa G. Specific recognition of cruciform DNA by nuclear protein HMG1. Science 243 (1989) 1056-1059
2. Bianchi M.E., and Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Curr. Opin. Genet. Dev. 15 (2005) 496-506
3. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999) 248-251
4. Scaffidi P., Misteli T., and Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 (2002) 191-195
5. Bianchi M.E., and Manfredi A. Chromatin and cell death. Biochim. Biophys. Acta 1677 (2004) 181-186
6. Dumitriu I.E., Baruah P., Manfredi A.A., Bianchi M.E., and Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol. 26 (2005) 381-387
7. Lotze M.T., and Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5 (2005) 331-342
8. Dumitriu I.E., Baruah P., Valentinis B., Voll R.E., Herrmann M., Nawroth P.P., Arnold B., Bianchi M.E., Manfredi A.A., and Rovere-Querini P. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J. Immunol. 174 (2005) 7506-7515
9. Rouhiainen A., Imai S., Rauvala H., and Parkkinen J. Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb. Haemost. 84 (2000) 1087-1094
10. Semino C., Angelini G., Poggi A., and Rubartelli A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106 (2005) 609-616
11. Gardella S., Andrei C., Ferrera D., Lotti L.V., Torrisi M.R., Bianchi M.E., and Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3 (2002) 995-1001
12. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., Rubartelli A., Agresti A., and Bianchi M.E. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22 (2003) 5551-5560
13. Youn J.H., and Shin J.S. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J. Immunol. 177 (2006) 7889-7897
14. Yang H., Wang H., Czura C.J., and Tracey K.J. The cytokine activity of HMGB1. J. Leukoc. Biol. 78 (2005) 1-8
15. Palumbo R., Sampaolesi M., De Marchis F., Tonlorenzi R., Colombetti S., Mondino A., Cossu G., and Bianchi M.E. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 164 (2004) 441-449
16. + cell proliferation and differentiation. Circ. Res. 97 (2005) e73-e83
17. Andersson U., and Erlandsson-Harris H. HMGB1 is a potent trigger of arthritis. J. Intern. Med. 255 (2004) 344-350
18. Wang H., Yang H., and Tracey K.J. Extracellular role of HMGB1 in inflammation and sepsis. J. Intern. Med. 255 (2004) 320-331
19. Porto A., Palumbo R., Pieroni M., Aprigliano G., Chiesa R., Sanvito F., Maseri A., and Bianchi M.E. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility protein box 1. FASEB J. 20 (2006) E1-E9
20. Vakkila J., and Lotze M.T. Inflammation and necrosis promote tumour growth. Nat. Rev. Immunol. 4 (2004) 641-648
21. Yang H., Ochani M., Li J., Qiang X., Tanovic M., Harris H.E., Susarla S.M., Ulloa L., Wang H., DiRaimo R., et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. USA 101 (2004) 296-301
22. Davis E.A., and Morris D.J. Medicinal uses of licorice through the millennia: the good and plenty of it. Mol. Cell. Endocrinol. 78 (1991) 1-6
23. Sitia G., Iannacone M., Muller S., Bianchi M.E., and Guidotti L.G. Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J. Leukoc. Biol. 81 (2007) 100-107
24. Degryse B., Bonaldi T., Scaffidi P., Muller S., Resnati M., Sanvito F., Arrigoni G., and Bianchi M.E. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152 (2001) 1197-1206
25. Knapp S., Muller S., Digilio G., Bonaldi T., Bianchi M.E., and Musco G. The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxes. Biochemistry 43 (2004) 11992-11997
26. Dominguez C., Boelens R., and Bonvin A.M. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125 (2003) 1731-1737
27. Schieborr U., Vogtherr M., Elshorst B., Betz M., Grimme S., Pescatore B., Langer T., Saxena K., and Schwalbe H. How much NMR data is required to determine a protein-ligand complex structure?. ChemBioChem 6 (2005) 1891-1898
28. Ohndorf U.M., Rould M.A., He Q., Pabo C.O., and Lippard S.J. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature 399 (1999) 708-712
29. Thomas J.O., and Travers A.A. HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem. Sci. 26 (2001) 167-174
30. Agresti A., Scaffidi P., Riva A., Caiolfa V.R., and Bianchi M.E. GR and HMGB1 interact only within chromatin and influence each other's residence time. Mol. Cell 18 (2005) 109-121
31. Hu H.Y., Horton J.K., Gryk M.R., Prasad R., Naron J.M., Sun D.A., Hecht S.M., Wilson S.H., and Mullen G.P. Identification of small molecule synthetic inhibitors of DNA polymerase β by NMR chemical shift mapping. J. Biol. Chem. 279 (2004) 39736-39744
32. Ploeger B., Mensinga T., Sips A., Seinen W., Meulenbelt J., and DeJongh J. The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab. Rev. 33 (2001) 125-147
33. Bianchi M.E., Falciola L., Ferrari S., and Lilley D.M.J. The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBO J. 11 (1992) 1055-1063
34. Chavakis T., Bierhaus A., Al-Fakhri N., Schneider D., Witte S., Linn T., Nagashima M., Morser J., Arnold B., Preissner K.T., and Nawroth P.P. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 198 (2003) 1507-1515
35. van Rossum T.G., Vulto A.G., Hop W.C., and Schalm S.W. Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C. Am. J. Gastroenterol. 96 (2001) 2432-2437
36. Yamamura Y., Kotaki H., Tanaka N., Aikawa T., Sawada Y., and Iga T. The pharmacokinetics of glycyrrhizin and its restorative effect on hepatic function in patients with chronic hepatitis and in chronically carbon-tetrachloride-intoxicated rats. Biopharm. Drug Dispos. 18 (1997) 717-725
37. Arase Y., Ikeda K., Murashima N., Chayama K., Tsubota A., Koida I., Suzuki Y., Saitoh S., Kobayashi M., and Kumada H. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 79 (1997) 1494-1500
38. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
39. Bartels C.-H., Xia T.-H., Billeter M., Güntert P., and Wütrich K. The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR 5 (1995) 1-10
40. Garrett D.S., Powers R., Gronenborn A.M., and Clore G.M. A common sense approach to peak picking two-, three- and four-dimensional spectra using automatic computer analysis of contour diagrams. J. Magn. Reson. 95 (1991) 214-220
41. Grzesiek S., Stahl S.J., Wingfield P.T., and Bax A. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry 35 (1996) 10256-10261
42. Johnson P.E., Tomme P., Joshi M.D., and McIntosh L.P. Interaction of soluble cellooligosaccharides with the N-terminal cellulose-binding domain of Cellulomonas fimi CenC. 2. NMR and ultraviolet absorption spectroscopy. Biochemistry 35 (1996) 13895-13906
43. Zwahlen C., Legault P., Vincent S.J.F., Greenblatt J., Konrat R., and Kay L.E. Methods for measurement of intermolecular NOEs by multinuclear NMR spectroscopy: application to a bacteriophage N-peptide/boxB RNA complex. J. Am. Chem. Soc. 119 (1997) 6711-6721
44. Nilges M., and O'Donoghue S.I. Ambiguous NOEs and automated NOE assignment. Prog. Nucleic Magn. Reson. Spectrosc. 32 (1998) 107-139
45. Schuettelkopf A.W., and Van Aalten D.M.F. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 60 (2004) 1355-1363
46. McLachlan A.D. Rapid comparison of protein structures. Acta Crystallogr. A 38 (1982) 871-873
47. Daura X., Gademann K., Jaun B., Seebach D., van Gunsteren W.F., and Mark A.E. Peptide folding: when simulation meets experiment. Angew. Chem. Int. Ed. 38 (1999) 236-240